This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Trefoil Therapeutics, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Jennifer Jenkins-Eveleth: Innovator in Fibroblast Growth Factor Therapeutics
Introduction
Jennifer Jenkins-Eveleth is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic applications involving fibroblast growth factors.
Latest Patents
Jennifer holds a patent for "Recombinant modified fibroblast growth factors and therapeutic uses thereof." This patent describes modified fibroblast growth factor (FGF) polypeptides, pharmaceutical compositions, and methods for using these modified FGFs to treat or prevent various medical conditions.
Career Highlights
Jennifer is currently associated with Trefoil Therapeutics, Inc., where she applies her expertise in biotechnology to advance therapeutic solutions. Her work focuses on innovative approaches to enhance the efficacy of fibroblast growth factors in medical treatments.
Collaborations
Jennifer collaborates with notable colleagues, including David Eveleth and Amuthakannan Subramaniam, to further her research and development efforts in the field.
Conclusion
Jennifer Jenkins-Eveleth is a trailblazer in the biotechnology sector, with her innovative work on fibroblast growth factors paving the way for new therapeutic options. Her contributions are vital to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile